지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.6
- 수록면
- 144 - 150 (7page)
- DOI
- https://doi.org/10.3904/kjm.2023.98.3.144
이용수
초록· 키워드
오류제보하기
Tyrosine kinase inhibitors (TKIs), such as imatinib, dasatinib, and nilotinib, have been used to treat chronic myelogenous leukemia (CML). The adverse effects of these TKIs vary according to the site of signaling pathway inhibition. Here, we report a case of dasatinib- induced proteinuria. A 56-year-old Korean woman was diagnosed with CML and treated with dasatinib. However, 3 years later, the patient developed hypertension and microalbuminuria. Losartan was ineffective, so a kidney biopsy was performed, which revealed dasatinib-associated glomerular changes. Subsequently, dasatinib was switched to nilotinib. After 1 month, the spot urine protein/creatinine ratio decreased from 2,985.0 mg/g to 237.8 mg/g. This case of heavy proteinuria developed after long-term TKI treatment and improved rapidly after switching to another TKI. The proposed strategy is important because it eliminates the need to discontinue the medication or use immunosuppressive drugs to treat proteinuria.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Nilotinib-Induced Acute Interstitial Nephritis during the Treatment of Chronic Myeloid Leukemia
고신대학교 의과대학 학술지
2021 .12
-
만성골수성백혈병의 타이로신인산화효소 억제제 치료 중 발생하는 혈관합병증
대한의사협회지
2023 .04
-
Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
Blood Research
2023 .04
-
Tyrosine Kinase Inhibitors in Ph+ Chronic Myeloid Leukemia Therapy: a Review
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Blood Research
2021 .12
-
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Blood Research
2022 .06
-
Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Blood Research
2023 .04
-
An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians
Korean Journal of Family Medicine
2015 .01
-
Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach
대한암예방학회지
2017 .01
-
직결장암 환자에서 Bevacizumab에 의한 단백뇨 발현과 치료효과와의 상관관계 분석
한국임상약학회지
2020 .01
-
A Case of Orthostatic Proteinuria Progressed to Persistent Proteinuria Associated with Renal Pathology
Childhood Kidney Diseases
2017 .01
-
Chronic Myeloid Leukemia - Prognostic Value of Mutations
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Clinical Approach to Children with Proteinuria
Childhood Kidney Diseases
2017 .01
-
Asciminib: the first-in-class allosteric inhibitor of BCR::ABL1 kinase
Blood Research
2023 .04
-
A Case Report of Multiple Capillary Hemangioma in a Chronic Myeloid Leukemia Patient Taking Tyrosine Kinase Inhibitors
Annals of Dermatology
2021 .01
-
Dysplastic Nevus with Eruptive Melanocytic Lesions That Developed during Nilotinib Therapy for Chronic Myeloid Leukemia
Annals of Dermatology
2015 .01
-
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
Annals of Laboratory Medicine
2016 .01
-
티로신키나아제 억제제 치료 후 발생한 중증 저칼슘혈증및 갑상선기능저하증 1례
International Journal of Thyroidology
2018 .01
-
Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia
Annals of Laboratory Medicine
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0